Huang Lijun, Fang Jiafeng, Wu Juekun, Zhou Xueling, Wei Hongbo
Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China, Email:
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Dec 25;21(12):1421-1426.
To investigate the prognostic value of preoperative serum tumor markers combined with peripheral blood routine indexes in colorectal cancer patients.
From January 2010 to March 2013, clinicopathological data of colorectal cancer patients receiving surgery treatment at the Third Affiliated Hospital of Sun Yat-sen University were collected.
(1) histologically confirmed adenocarcinoma; (2) primary cancer resected; (3) intact clinical data; (4) no signs of clinical infection. Patients with intestinal perforation or obstruction, hematological diseases or other malignant tumors were excluded. Informations were recorded containing sex, age, tumor location, degree of differentiation, tumor size, vascular tumor thrombus, nerve invasion, depth of infiltration, lymph node metastasis, distant metastasis, TNM stage, peripheral serum CEA, CA199, number of neutrophil, monocyte, platelet and lymphocyte. Positive CEA was defined as ≥5 μg/L, CA199 as ≥35 U/L; while NLR (neutrophil-to-lymphocyte ratio), MLR (monocyte-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio) greater than their cut-off values were defined as positive. ROC curve was used to determine the cut-off values (with greatest area under curve) of NLR, MLR and PLR. The prognostic values of these indexes were analyzed using Kaplan-Meier regression and log-rank test. COX regression was used to perform risk factor analysis.
A total of 312 colorectal cancer patients were enrolled, including 192 males and 120 females with median age of 61 (15-85) years. Till March 11, 2018, during median follow-up period of 65 months(2-96), the follow-up rate was 90.4% with loss of 30 cases and the mortality was 37.2% with 116 death. Univariate analysis found that colorectal cancer patients with positive CEA, CA199, NLR (>2.32), MLR (>0.24) and PLR (>164.1) had poor prognosis (all P<0.01). When combining CEA, CA199 with NLR, MLR, PLR, the survival analysis showed that patients with both negative indexes had the best prognosis, one positive the worse and both positive were the worst (all P<0.01). COX regression revealed that CEA(HR= 1.702,95%CI:1.148-2.522, P<0.01), combination of CA199 and MLR (HR=2.292, 95%CI:1.426-3.683, P<0.01) were independent risk factors for colorectal cancer.
Combination of preoperative serum tumor markers and peripheral blood routine indexes can provide prognostic information for the patients with colorectal cancer.
探讨术前血清肿瘤标志物联合外周血常规指标对结直肠癌患者的预后价值。
收集2010年1月至2013年3月在中山大学附属第三医院接受手术治疗的结直肠癌患者的临床病理资料。
(1)组织学确诊为腺癌;(2)原发性癌已切除;(3)临床资料完整;(4)无临床感染迹象。排除肠穿孔或梗阻、血液系统疾病或其他恶性肿瘤患者。记录患者的性别、年龄、肿瘤部位、分化程度、肿瘤大小、血管肿瘤血栓、神经侵犯、浸润深度、淋巴结转移、远处转移、TNM分期、外周血清癌胚抗原(CEA)、糖类抗原199(CA199)、中性粒细胞、单核细胞、血小板及淋巴细胞数量。CEA阳性定义为≥5μg/L,CA199阳性定义为≥35U/L;中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、血小板与淋巴细胞比值(PLR)大于其临界值定义为阳性。采用ROC曲线确定NLR、MLR和PLR的临界值(曲线下面积最大)。采用Kaplan-Meier回归和log-rank检验分析这些指标的预后价值。采用COX回归进行危险因素分析。
共纳入312例结直肠癌患者,其中男性192例,女性120例,中位年龄61岁(15 - 85岁)。截至2018年3月11日,中位随访时间65个月(2 - 96个月),随访率为90.4%,失访30例,死亡率为37.2%,死亡116例。单因素分析发现,CEA、CA199、NLR(>2.32)、MLR(>0.24)和PLR(>164.1)阳性的结直肠癌患者预后较差(均P<0.01)。当将CEA、CA199与NLR、MLR、PLR联合分析时,生存分析显示指标均为阴性的患者预后最佳,一项阳性者预后较差,两项均阳性者预后最差(均P<0.01)。COX回归显示,CEA(风险比[HR]=1.702,95%置信区间[CI]:1.148 - 2.522,P<0.01)、CA199与MLR联合(HR=2.292,95%CI:1.426 - 3.683,P<0.01)是结直肠癌的独立危险因素。
术前血清肿瘤标志物与外周血常规指标联合可为结直肠癌患者提供预后信息。